SOAP-n-SCENT CO., LTD.
⚠️ High Risk
FEI: 3006553163 • Changklan, Chiangmai • THAILAND
FEI Number
3006553163
Location
Changklan, Chiangmai
Country
THAILANDAddress
327/9 Soi Srijundorn 2, Jareonprated Rd., Changklan, Chiangmai, Thailand
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 2/26/2010 | 66VBU99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 11/3/2009 | 63WBU02GREEN SOAP (DETERGENT) | San Francisco District Office (SAN-DO) | |
| 11/3/2009 | 63WBU02GREEN SOAP (DETERGENT) | 75UNAPPROVED | San Francisco District Office (SAN-DO) |
Frequently Asked Questions
What is SOAP-n-SCENT CO., LTD.'s FDA import refusal history?
SOAP-n-SCENT CO., LTD. (FEI: 3006553163) has 16 FDA import refusal record(s) in our database, spanning from 11/3/2009 to 2/26/2010.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SOAP-n-SCENT CO., LTD.'s FEI number is 3006553163.
What types of violations has SOAP-n-SCENT CO., LTD. received?
SOAP-n-SCENT CO., LTD. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about SOAP-n-SCENT CO., LTD. come from?
All FDA import refusal data for SOAP-n-SCENT CO., LTD. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.